Sunday, October 23, 2011

Kentucky Reaches Settlement With Pfizer, Inc.

{Kentucky}...Attorney General Jack Conway has announced that Kentucky has reached a settlement with pharmaceutical giant Pfizer, Inc. over allegations of illegal off-label marketing of its urology drug Detrol. The settlement concludes a government investigation into the allegations that the company engaged in off-label marketing schemes to promote the sales of Detrol for uses that were not approved by the Food and Drug Administration (FDA). The settlement will return $152,607 to the state's Medicaid program. The FDA approved Detrol in March 1998 for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency.